E Varečková

1.2k total citations
48 papers, 936 citations indexed

About

E Varečková is a scholar working on Epidemiology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, E Varečková has authored 48 papers receiving a total of 936 indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Epidemiology, 17 papers in Immunology and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in E Varečková's work include Influenza Virus Research Studies (42 papers), Respiratory viral infections research (25 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). E Varečková is often cited by papers focused on Influenza Virus Research Studies (42 papers), Respiratory viral infections research (25 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). E Varečková collaborates with scholars based in Slovakia, United States and Czechia. E Varečková's co-authors include F Kostolanský, V. Mucha, G Russ, Tatiana Betáková, Ondřej Zítka, Jaroslav Hollý, Vladimír Pekařík, Zbyněk Heger, Ludmila Krejčová and Vojtěch Adam and has published in prestigious journals such as PLoS ONE, Journal of Clinical Microbiology and Virology.

In The Last Decade

E Varečková

45 papers receiving 915 citations

Peers

Countries citing papers authored by E Varečková

Since Specialization

Citations

This map shows the geographic impact of E Varečková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Varečková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Varečková more than expected).

Fields of papers citing papers by E Varečková

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Varečková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Varečková. The network helps show where E Varečková may publish in the future.

Co-authorship network of co-authors of E Varečková

This figure shows the co-authorship network connecting the top 25 collaborators of E Varečková. A scholar is included among the top collaborators of E Varečková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Varečková. E Varečková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Protective efficacy of the UniFluVec influenza vaccine vector against the highly pathogenic influenza A/Indonesia/5/2005 (H5N1) strain in ferrets 2025 ·Vaccine ·Julia Romanova, (unknown), Boris Ferko, (unknown), E Varečková, F Kostolanský, Andrej Egorov	0
2	The Contribution of Viral Proteins to the Synergy of Influenza and Bacterial Co-Infection 2022 ·Viruses ·(unknown), (unknown), (unknown), F Kostolanský, E Varečková	9
3	Quantification of bacteria by in vivo bioluminescence imaging in comparison with standard spread plate method and reverse transcription quantitative PCR (RT-qPCR) 2021 ·Archives of Microbiology ·(unknown), (unknown), (unknown), F Kostolanský, E Varečková	5
4	Biological properties of influenza A virus mutants with amino acid substitutions in the HA2 glycoprotein of the HA1/HA2 interaction region 2019 ·Journal of General Virology ·(unknown), (unknown), Jaroslav Hollý, (unknown), (unknown), Katarína Polčicová, F Kostolanský, Ervin Fodor, E Varečková	8
5	Comparison of infectious influenza A virus quantification methods employing immuno-staining 2017 ·Journal of Virological Methods ·Jaroslav Hollý, (unknown), (unknown), (unknown), (unknown), E Varečková, F Kostolanský	15
6	Perspective of Use of Antiviral Peptides against Influenza Virus 2015 ·Viruses ·Sylvie Skalíčková, Zbyněk Heger, Ludmila Krejčová, Vladimír Pekařík, (unknown), J Janda, F Kostolanský, E Varečková, Ondřej Zítka, Vojtěch Adam, René Kizek	111
7	The Ubiquitination of the Influenza A Virus PB1-F2 Protein Is Crucial for Its Biological Function 2015 ·PLoS ONE ·Ivan Košík, (unknown), Martina Košíková, (unknown), Jaroslav Hollý, E Varečková, F Kostolanský, Gustáv Russ	16
8	Epitope specificity of anti‐HA2 antibodies induced in humans during influenza infection 2012 ·Influenza and Other Respiratory Viruses ·(unknown), V. Mucha, (unknown), (unknown), F Kostolanský, E Varečková	18
9	Two distinct regions of HA2 glycopolypeptide of influenza virus hemagglutinin elicit cross-protective immunity against influenza 2012 ·Acta Virologica ·(unknown), (unknown), V. Mucha, F Kostolanský, E Varečková	17
10	Heterosubtypic protection against influenza A induced by adenylate cyclase toxoids delivering conserved HA2 subunit of hemagglutinin 2012 ·Antiviral Research ·(unknown), Irena Adkins, (unknown), (unknown), Peter Šebo, E Varečková	28
11	Evaluation of anti-influenza efficiency of polyclonal IgG antibodies specific to the ectodomain of M2 protein of influenza A virus by passive immunization of mice 2011 ·Acta Virologica ·(unknown), E Varečková, V. Mucha, F Kostolanský	9
12	Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development 2010 ·Virology Journal ·(unknown), E Varečková	133
13	Multiorgan distribution of human influenza A virus strains observed in a mouse model 2009 ·Archives of Virology ·(unknown), (unknown), (unknown), Vladimı́ra Ďurmanová, J Rajcáni, E Varečková, V. Mucha, F Kostolanský	57
14	Single residue deletions along the length of the influenza HA fusion peptide lead to inhibition of membrane fusion function 2009 ·Virology ·William A. Langley, (unknown), Konrad C. Bradley, Summer E. Galloway, Ganesh R. Talekar, (unknown), E Varečková, (unknown), David A. Steinhauer	13
15	Broadly cross-reactive monoclonal antibodies against HA2 glycopeptide of Influenza A virus hemagglutinin of H3 subtype reduce replication of influenza A viruses of human and avian origin 2009 ·Acta Virologica ·(unknown), V. Mucha, (unknown), (unknown), F Kostolanský, E Varečková	23
16	HA2-specific monoclonal antibodies as tools for differential recognition of influenza A virus antigenic subtypes 2007 ·Virus Research ·E Varečková, V. Mucha, F Kostolanský, Larisa V. Gubareva, Alexander Klimov	29
17	Comparison of 44/107L one-step immunocapture enzyme-immunoassay and time-resolved fluoroimmunoassay for influenza A diagnosis 2001 ·Journal of Virological Methods ·E Varečková, (unknown), (unknown), V. Mucha, Matti Waris	3
18	Effects of brefeldin A on the expression and transport of influenza A virus haemagglutinin, M1 and M2 proteins within the cell. 1997 ·PubMed ·Fedor Čiampor, (unknown), Dušan Cmarko, (unknown), E Varečková	4
19	A competitive-inhibition radioimmunoassay for influenza virus envelope antigens. 1976 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·G Russ, B Styk, K Poláková, E Varečková	5
20	Steric effects in the reaction of influenza virus neuraminidases with antibodies. 1974 ·Acta Virologica ·G Russ, E Varečková, B Styk	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact